Belite Bio (BLTE) Tops Q3 EPS by 1c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Upgrades LTM Ltd (LTM:IN) to Buy (1)
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance